| P2093 | author name string | F W A Verheugt | |
| P2860 | cites work | Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial | Q44672192 |
| | Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial | Q45258336 |
| | Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study | Q56680969 |
| | Good old warfarin for stroke prevention in atrial fibrillation | Q83963699 |
| | Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial | Q26248603 |
| | Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation | Q28188284 |
| | Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force | Q28192096 |
| | Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial | Q28193437 |
| | Warfarin, aspirin, or both after myocardial infarction | Q28193836 |
| | Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events | Q28195656 |
| | Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation | Q28201331 |
| | Stroke prevention in elderly patients with atrial fibrillation | Q28219361 |
| | Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial | Q28219363 |
| | Validation of Clinical Classification Schemes for Predicting Stroke | Q29028208 |
| | Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin | Q33671179 |
| | Antithrombotic therapy for atrial fibrillation | Q33812662 |
| | The natural history of lone atrial fibrillation. A population-based study over three decades | Q34186025 |
| | Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study | Q34186228 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial | Q34607209 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty | Q34789112 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty | Q34789118 |
| | Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial | Q34789474 |
| | Anticoagulants in heart disease: current status and perspectives | Q36787643 |
| P433 | issue | 6 | |
| P921 | main subject | anticoagulation | Q63279445 |
| P304 | page(s) | 314-318 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Netherlands Heart Journal | Q2146163 |
| P1476 | title | The new oral anticoagulants | |
| P478 | volume | 18 | |